Endogenous Retrovirus RNA Expression Differences between Race, Stage and HPV Status Offer Improved Prognostication among Women with Cervical Cancer

Keyphrases

• Cervical Cancer 100%
• RNA Expression 100%
• Human Retrovirus 100%
• Expression Difference 100%
• HPV Status 100%
• Endogenous Retrovirus 100%
• Gene Signature 17%
• HERVH 17%
• Tumor 11%
• Protein Expression 11%
• Expression Level 11%
• Clinical Factors 11%
• Prediction Model 11%
• Locally Advanced Stage 11%
• Prognosticator 11%
• Differentially Expressed 11%
• Cervical Cancer Patients 11%
• Cancer Tumor 5%
• Protein Level 5%
• Therapeutic Target 5%
• Tissue Microarray 5%
• Clinical Data 5%
• Cox Proportional Hazards Model 5%
• African American 5%
• Patient Survival 5%
• Baseline Predictors 5%
• Publicly Available 5%
• White Americans 5%
• Tumor Stage 5%
• Tumor Biopsy 5%
• Clinical Parameters 5%
• Future Therapeutics 5%
• Recurrence Risk 5%
• Tumor Patients 5%
• Differential Expression 5%
• Disease Stage 5%
• Prognostic Biomarker 5%
• Human Genome 5%
• RNA-seq Data 5%
• Prognostic Model 5%
• Signature Genes 5%
• HERV-K 5%
• Adjacent Genes 5%
• Prognostic Power 5%
• Protein-coding Potential 5%
• FIGO Stage 5%
• Four Aspects 5%
• Ancestral Background 5%
• LASSO Cox 5%
• HPV Types 5%
• Therapeutic Interventions 5%
• Exogenous Retrovirus 5%
• HPV-positive 5%
• Model Developing 5%

Biochemistry, Genetics and Molecular Biology

• RNA 100%
• Endogenous Retrovirus 100%
• Protein Expression 11%
• Cancer Staging 11%
• Expression Level 11%
• Human Genome 5%
• RNA Sequencing 5%
• Tissue Microarray 5%
• Retrovirus 5%
• Prognostic Biomarker 5%

Immunology and Microbiology

• Endogenous Retrovirus 100%
• Ribonucleic Acid 100%
• Protein Expression 11%
• Cancer Staging 11%
• RNA Sequencing 5%
• Retrovirus 5%
• Human Genome 5%
• Prognostic Biomarker 5%
• Prognostic Model 5%
• Therapeutic Target 5%